These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 28837897)

  • 1. Effects of ABCB1, ABCC2, UGT2B7 and HNF4α genetic polymorphisms on oxcarbazepine concentrations and therapeutic efficacy in patients with epilepsy.
    Shen C; Zhang B; Liu Z; Tang Y; Zhang Y; Wang S; Guo Y; Ding Y; Wang S; Ding M
    Seizure; 2017 Oct; 51():102-106. PubMed ID: 28837897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of oxcarbazepine efficacy and MHD concentrations relative to age and BMI: Associations among ABCB1, ABCC2, UGT2B7, and SCN2A polymorphisms.
    Yang X; Yan Y; Fang S; Zeng S; Ma H; Qian L; Chen X; Wei J; Gong Z; Xu Z
    Medicine (Baltimore); 2019 Mar; 98(12):e14908. PubMed ID: 30896644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific OCT1 and ABCG2 polymorphisms are associated with Lamotrigine concentrations in Chinese patients with epilepsy.
    Shen CH; Zhang YX; Lu RY; Jin B; Wang S; Liu ZR; Tang YL; Ding MP
    Epilepsy Res; 2016 Nov; 127():186-190. PubMed ID: 27610747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First Analysis of the Association Between CYP3A4/5, ABCB1 Genetic Polymorphisms and Oxcarbazepine Metabolism and Transport in Chinese Epileptic Patients with Oxcarbazepine Monotherapy and Bitherapy.
    Wang P; Yin T; Ma HY; Liu DQ; Sheng YA; Zhou BT
    J Pharm Pharm Sci; 2015; 18(3):256-65. PubMed ID: 26517132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SCN1A, ABCC2 and UGT2B7 gene polymorphisms in association with individualized oxcarbazepine therapy.
    Ma CL; Wu XY; Jiao Z; Hong Z; Wu ZY; Zhong MK
    Pharmacogenomics; 2015; 16(4):347-60. PubMed ID: 25823783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population pharmacokinetics of oxcarbazepine active metabolite in Chinese paediatric epilepsy patients and its application in individualised dosage regimens.
    Lin WW; Li XW; Jiao Z; Zhang J; Rao X; Zeng DY; Lin XH; Wang CL
    Eur J Clin Pharmacol; 2019 Mar; 75(3):381-392. PubMed ID: 30456415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of UGT1A9 genetic polymorphisms on monohydroxylated derivative of oxcarbazepine concentrations and oxcarbazepine monotherapeutic efficacy in Chinese patients with epilepsy.
    Lu Y; Fang Y; Wu X; Ma C; Wang Y; Xu L
    Eur J Clin Pharmacol; 2017 Mar; 73(3):307-315. PubMed ID: 27900402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABCC2 polymorphisms and haplotype are associated with drug resistance in Chinese epileptic patients.
    Qu J; Zhou BT; Yin JY; Xu XJ; Zhao YC; Lei GH; Tang Q; Zhou HH; Liu ZQ
    CNS Neurosci Ther; 2012 Aug; 18(8):647-51. PubMed ID: 22630058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between the polymorphisms in the ATP-binding cassette genes ABCB1 and ABCC2 and the risk of drug-resistant epilepsy in a Chinese Han population.
    Xue T; Lu ZN
    Genet Mol Res; 2016 Nov; 15(4):. PubMed ID: 27886333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms of ABCG2, ABCB1 and HNF4α are associated with Lamotrigine trough concentrations in epilepsy patients.
    Zhou Y; Wang X; Li H; Zhang J; Chen Z; Xie W; Zhang J; Li J; Zhou L; Huang M
    Drug Metab Pharmacokinet; 2015 Aug; 30(4):282-7. PubMed ID: 26213157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of ABCC2 genotype on antiepileptic drug response in Caucasian patients with childhood epilepsy.
    Ufer M; von Stülpnagel C; Muhle H; Haenisch S; Remmler C; Majed A; Plischke H; Stephani U; Kluger G; Cascorbi I
    Pharmacogenet Genomics; 2011 Oct; 21(10):624-30. PubMed ID: 21799461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ABCB1 polymorphisms on plasma carbamazepine concentrations and pharmacoresistance in Chinese patients with epilepsy.
    Meng H; Guo G; Ren J; Zhou H; Ge Y; Guo Y
    Epilepsy Behav; 2011 May; 21(1):27-30. PubMed ID: 21493161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetics of oxcarbazepine 10-monohydroxy derivative in Chinese adult epileptic patients.
    Yang Q; Hu Y; Zhang X; Zhang X; Dai H; Li X
    Eur J Hosp Pharm; 2023 Mar; 30(e1):e90-e96. PubMed ID: 35787526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-response to antiepileptic pharmacotherapy is associated with the ABCC2 -24C>T polymorphism in young and adult patients with epilepsy.
    Ufer M; Mosyagin I; Muhle H; Jacobsen T; Haenisch S; Häsler R; Faltraco F; Remmler C; von Spiczak S; Kroemer HK; Runge U; Boor R; Stephani U; Cascorbi I
    Pharmacogenet Genomics; 2009 May; 19(5):353-62. PubMed ID: 19415824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glomerular Filtration Rate Is a Major Predictor of Clearance of Oxcarbazepine Active Metabolite in Adult Chinese Epileptic Patients: A Population Pharmacokinetic Analysis.
    Lin WW; Wang CL; Jiao Z; Yu XL; Zhang J; Zhang WB; Lin RF; Lin S; Lin XH
    Ther Drug Monit; 2019 Oct; 41(5):665-673. PubMed ID: 31033858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ABCB1, ABCC2, SCN1A, SCN2A, GABRA1 gene polymorphisms and drug resistant epilepsy in the Chinese Han population.
    Zhou L; Cao Y; Long H; Long L; Xu L; Liu Z; Zhang Y; Xiao B
    Pharmazie; 2015 Jun; 70(6):416-20. PubMed ID: 26189305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of SCN1A, SCN2A and ABCC2 gene polymorphisms with the response to antiepileptic drugs in Chinese Han patients with epilepsy.
    Ma CL; Wu XY; Zheng J; Wu ZY; Hong Z; Zhong MK
    Pharmacogenomics; 2014 Jul; 15(10):1323-36. PubMed ID: 25155934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of CYP3A5 and UGT2B7 variants on steady-state carbamazepine concentrations in Chinese epileptic patients.
    Lu Q; Huang YT; Shu Y; Xu P; Xiang DX; Qu Q; Qu J
    Medicine (Baltimore); 2018 Jul; 97(30):e11662. PubMed ID: 30045320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of carbamazepine major metabolism and transport pathway gene polymorphisms and pharmacokinetics in patients with epilepsy.
    Puranik YG; Birnbaum AK; Marino SE; Ahmed G; Cloyd JC; Remmel RP; Leppik IE; Lamba JK
    Pharmacogenomics; 2013 Jan; 14(1):35-45. PubMed ID: 23252947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of influencing factors on monohydroxylated derivative of oxcarbazepine plasma concentration in children with epilepsy.
    Yao N; Huang S; Huang A; Song H
    Eur J Clin Pharmacol; 2022 Oct; 78(10):1667-1675. PubMed ID: 36006433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.